Literature DB >> 6481861

The risk of vascular surgery in a metropolitan community. With observations on surgeon experience and hospital size.

N R Hertzer, J C Avellone, C J Farrell, F R Plecha, R S Rhodes, W V Sharp, G F Wright.   

Abstract

From 1978 through 1981 complete perioperative information concerning a total of 10,189 peripheral vascular procedures performed in northeastern Ohio was recorded in the computer registry of The Cleveland Vascular Society. This report is an analysis of mortality and morbidity rates for all 5686 operations involving carotid endarterectomy (N = 2646), lower extremity revascularization (N = 1987), and abdominal aortic aneurysm resection (N = 1053). The operative mortality rate was 1.2% for carotid reconstruction, 2.8% for femoropopliteal or distal bypass, 3.5% for aortofemoral revascularization, and 11.9% for aortic aneurysm resection (elective operations 6.5%; emergency operations 32.9%). Postoperative strokes occurred after endarterectomy in 2.7% of patients having preoperative neurologic symptoms and in 2.0% of those with asymptomatic carotid stenosis. Lower extremity amputation was unavoidable in 1.5% of patients after aortofemoral reconstruction and in 6.0% after femoropopliteal or distal bypass. Statistical testing indicated that the operative mortality rate was not related to the respective size of the 27 hospitals involved in the survey. The relative annual experience of the 29 participating surgeons significantly influenced only the mortality rate of elective aneurysm resection and the amputation rate after femoropopliteal or distal revascularization. This study suggests that the results of major arterial reconstruction in metropolitan areas may be expected to be comparable to those of published series if the responsible surgeons are specifically trained and maintain an active interest in the field of vascular surgery.

Entities:  

Mesh:

Year:  1984        PMID: 6481861

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  13 in total

1.  Impact of race on the outcome of carotid endarterectomy: a population-based analysis of 9,842 recent elective procedures.

Authors:  A Dardik; H M Bowman; T A Gordon; G Hsieh; B A Perler
Journal:  Ann Surg       Date:  2000-11       Impact factor: 12.969

Review 2.  The case against a national screening programme for aortic aneurysms.

Authors:  T R Cheatle
Journal:  Ann R Coll Surg Engl       Date:  1997-03       Impact factor: 1.891

3.  Risk of carotid endarterectomy in the elderly.

Authors:  E S Fisher; D J Malenka; N A Solomon; T A Bubolz; F S Whaley; J E Wennberg
Journal:  Am J Public Health       Date:  1989-12       Impact factor: 9.308

4.  Mortality after elective abdominal aortic aneurysm repair: not where ... but how many and by whom.

Authors:  R B Galland; J H Wolfe
Journal:  Ann R Coll Surg Engl       Date:  1998-09       Impact factor: 1.891

5.  Vascular surgery and accreditation.

Authors:  R V Rao
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

6.  Recurrent carotid stenosis. A five-year series of 65 reoperations.

Authors:  M B Das; N R Hertzer; N B Ratliff; P J O'Hara; E G Beven
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

7.  The mortality of abdominal aortic aneurysm.

Authors:  W B Campbell; J Collin; P J Morris
Journal:  Ann R Coll Surg Engl       Date:  1986-09       Impact factor: 1.891

8.  Surgical versus nonoperative treatment of asymptomatic carotid stenosis. 290 patients documented by intravenous angiography.

Authors:  N R Hertzer; R A Flanagan; E G Beven; P J O'Hara
Journal:  Ann Surg       Date:  1986-08       Impact factor: 12.969

Review 9.  Prognosis after graft replacement operation for abdominal aortic aneurysm.

Authors:  J Feinglass; W H Pearce; G J Martin
Journal:  West J Med       Date:  1993-10

10.  Current status of the use of retroperitoneal approach for reconstructions of the aorta and its branches.

Authors:  C Darling; D M Shah; B B Chang; P S Paty; R P Leather
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.